牛牛AI助理已提取核心訊息
Joseph J Wolk, the Executive Vice President and Chief Financial Officer of Johnson & Johnson, was involved in a transaction with the company's stock on February 15, 2024. The specific details of the transaction, such as the action type, number of shares, nature of shares, transaction price, and total value of shares, were not disclosed in the announcement. The report also did not provide information on the number of shares held by Wolk after the transaction. The absence of these details leaves a gap in the full understanding of the transaction's impact on Wolk's holdings and the company's stock.
Joseph J Wolk, the Executive Vice President and Chief Financial Officer of Johnson & Johnson, was involved in a transaction with the company's stock on February 15, 2024. The specific details of the transaction, such as the action type, number of shares, nature of shares, transaction price, and total value of shares, were not disclosed in the announcement. The report also did not provide information on the number of shares held by Wolk after the transaction. The absence of these details leaves a gap in the full understanding of the transaction's impact on Wolk's holdings and the company's stock.
強生公司執行副總裁兼首席財務官約瑟夫·沃爾克於2024年2月15日參與了與該公司股票的交易。公告中未披露交易的具體細節，例如行動類型、股票數量、股票性質、交易價格和股票總價值。該報告也沒有提供有關沃爾克在交易後持有的股票數量的信息。缺乏這些細節使人們無法充分了解該交易對沃爾克持股和公司股票的影響。
強生公司執行副總裁兼首席財務官約瑟夫·沃爾克於2024年2月15日參與了與該公司股票的交易。公告中未披露交易的具體細節，例如行動類型、股票數量、股票性質、交易價格和股票總價值。該報告也沒有提供有關沃爾克在交易後持有的股票數量的信息。缺乏這些細節使人們無法充分了解該交易對沃爾克持股和公司股票的影響。
有用
沒用